| Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats S Shklyaev, G Aslanidi, M Tennant, V Prima, E Kohlbrenner, V Kroutov, ... Proceedings of the National Academy of Sciences 100 (24), 14217-14222, 2003 | 309 | 2003 |
| Structure of adeno-associated virus serotype 8, a gene therapy vector HJ Nam, MD Lane, E Padron, B Gurda, R McKenna, E Kohlbrenner, ... Journal of virology 81 (22), 12260-12271, 2007 | 271 | 2007 |
| Structural insight into the unique properties of adeno-associated virus serotype 9 MA DiMattia, HJ Nam, K Van Vliet, M Mitchell, A Bennett, BL Gurda, ... Journal of virology 86 (12), 6947-6958, 2012 | 220 | 2012 |
| Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors CN Kay, RC Ryals, GV Aslanidi, SH Min, Q Ruan, J Sun, FM Dyka, ... PloS one 8 (4), e62097, 2013 | 189 | 2013 |
| High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines DM Markusic, RW Herzog, GV Aslanidi, BE Hoffman, B Li, M Li, ... Molecular Therapy 18 (12), 2048-2056, 2010 | 161 | 2010 |
| Innate immune responses to AAV vectors GL Rogers, AT Martino, GV Aslanidi, GR Jayandharan, A Srivastava, ... Frontiers in microbiology 2, 194, 2011 | 156 | 2011 |
| Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system E Kohlbrenner, G Aslanidi, K Nash, S Shklyaev, M Campbell-Thompson, ... Molecular therapy 12 (6), 1217-1225, 2005 | 151 | 2005 |
| Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold? GV Aslanidi, AE Rivers, L Ortiz, L Song, C Ling, L Govindasamy, ... PloS one 8 (3), e59142, 2013 | 127 | 2013 |
| An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells G Aslanidi, K Lamb, S Zolotukhin Proceedings of the National Academy of Sciences 106 (13), 5059-5064, 2009 | 104 | 2009 |
| Microglia-specific targeting by novel capsid-modified AAV6 vectors AM Rosario, PE Cruz, C Ceballos-Diaz, MR Strickland, Z Siemienski, ... Molecular Therapy-Methods & Clinical Development 3, 2016 | 100 | 2016 |
| Salivary PYY: a putative bypass to satiety A Acosta, MD Hurtado, O Gorbatyuk, M La Sala, D Duncan, G Aslanidi, ... PloS one 6 (10), e26137, 2011 | 87 | 2011 |
| Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo Y Zhang, Y Wang, AH Yusufali, F Ashby, D Zhang, Z Yin, GV Aslanidi, ... Journal of integrative medicine 12 (6), 483-494, 2014 | 86 | 2014 |
| Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells B Cheng, C Ling, Y Dai, Y Lu, LG Glushakova, SWY Gee, KE McGoogan, ... Gene therapy 19 (4), 375-384, 2012 | 85 | 2012 |
| Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo L Song, MA Kauss, E Kopin, M Chandra, T Ul-Hasan, E Miller, ... Cytotherapy 15 (8), 986-998, 2013 | 75 | 2013 |
| High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors GV Aslanidi, AE Rivers, L Ortiz, L Govindasamy, C Ling, GR Jayandharan, ... Vaccine 30 (26), 3908-3917, 2012 | 62 | 2012 |
| Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo L Wang, Y Wang, Y Lu, Z Yin, Y Zhang, GV Aslanidi, A Srivastava, C Ling, ... Journal of integrative medicine 12 (1), 20-34, 2014 | 61 | 2014 |
| Enhanced Transgene Expression from Recombinant Single-Stranded D-Sequence-Substituted Adeno-Associated Virus Vectors in Human Cell Lines In Vitro and in Murine … C Ling, Y Wang, Y Lu, L Wang, GR Jayandharan, GV Aslanidi, B Li, ... Journal of virology 89 (2), 952-961, 2015 | 60 | 2015 |
| High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine … L Song, X Li, GR Jayandharan, Y Wang, GV Aslanidi, C Ling, L Zhong, ... PLoS One 8 (3), e58757, 2013 | 58 | 2013 |
| Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo B Li, W Ma, C Ling, K Van Vliet, LY Huang, M Agbandje-McKenna, ... Human gene therapy methods 26 (6), 211-220, 2015 | 55 | 2015 |
| Capsid-modified rAAV vector compositions and methods therefor A Srivastava, GV Aslanidi, S Zolotukhin, M Agbandje-McKenna, ... US Patent 10,011,640, 2018 | 50 | 2018 |
Sergei ZolotukhinProfessor of Pediatrics在 ufl.edu 的电子邮件经过验证
